Physician profile
Olivia A Cooley
NPI 1952023996
$1,682.49
in general payments reported to CMS, 2019-2025
14 companies · $717 in 2025
The $717 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $505 · 2024: $460 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,682.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $323.63 | 2023-2025 | Belbuca, Xtampza |
| Spinal Simplicity, LLC | $309.31 | 2023-2024 | Ha Minuteman G3-R |
| Pfizer INC. | $257.96 | 2023-2025 | |
| Nalu Medical, INC. | $148.83 | 2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $148.36 | 2025 | Omnia |
| Curonix LLC | $147.46 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.94 | 2023-2024 | Relistor |
| Abbvie INC. | $67.13 | 2023-2024 | |
| Halozyme INC | $44.05 | 2023 | |
| Lundbeck LLC | $42.53 | 2024-2025 | Vyepti |
| Radius Health, INC. | $37.92 | 2023-2024 | Tymlos |
| Scilex Pharmaceuticals INC. | $35.80 | 2023-2024 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $13.72 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $12.85 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.